GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
COPD is the elephant in the room for many patients with CVDs. It is a prevalent, preventable, and treatable condition, but most often it has not been diagnosed and, hence, not treated appropriately [2]. Importantly for cardiology practice, optimal management of COPD is associated with improved cardiovascular outcomes [66]. Yet, such clinical management requires, to begin with, a high level of suspicion and appropriate confirmation of diagnosis by spirometry. Initial treatment should focus on smoking abstinence and use of one or two long-acting bronchodilators. Referral to specialized pulmonary care is advised if response to treatment is not satisfactory.
Puedes leer el artículo completo aquí: https://link.springer.com/article/10.1007/s00392-023-02217-0
Noticias relacionadas

THE P4COPD STUDY: RATIONALE, GOALS AND STUDY DESIGN Prediction, Prevention, Personalized and Precision management of COPD in young adults
El estudio P4COPD investiga cómo predecir, prevenir y personalizar el manejo de la pre-EPOC en adultos jóvenes mediante medicina de precisión y biomarcadores.

Jornada RespirAP 2026: conexión entre Atención Primaria y Neumología para mejorar la atención al paciente respiratorio
Jornada RespirAP 2026 con las principales novedades en enfermedades respiratorias, Atención Primaria y Neumología presentadas por expertos nacionales.

The EXACERBANTES Study (Exacerbation of Chronic Obstructive Pulmonary Disease According to the ANTES Proposal): Rationale, Goals and Design
The EXACERBANTES Study explores treatable traits in COPD exacerbations, aiming to improve risk assessment and support personalized clinical management.
Más artículos
EPOC
- 759788·Alvar Agustí, Rod Hughes, Eleni Rapsomaki, Barry Make, Ricardo Del Olmo, Alberto Papi, David Price, Laura Benton, Stefan Franzen, Jørgen Vestbo, Hana Mullerova – The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort
- 759883·Alberto Papi, Rosa Faner, Ian Pavord, Federico Baraldi, Vanessa M McDonald, Mike Thomas, Marc Miravitlles, Nicholas Roche, Alvar Agustí. – From treatable traits to GETomics in airway disease: moving towards clinical practice
- 768778·Alvar Agusti, Claus F. Vogelmeier – GOLD 2024: a brief overview of key changes
- 768799·Surya P Bhatt Richard Casaburi Alvar Agusti et Al. Chronic obstructive pulmonary disease: hiding in plain sight, a Statement from the COPD Foundation Medical and Scientific Advisory Committee
- 769092·Leonardo M Fabbri et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida en el artículo original.